Related Experiment Video

Updated: Jun 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

ODE models for oncolytic virus dynamics

Natalia L Komarova1, Dominik Wodarz

  • 1Department of Mathematics, 340 Rowland Hall, University of California, Irvine, CA 92697, USA. komarova@uci.edu

Journal of Theoretical Biology
|January 21, 2010
PubMed

Insights

Mathematical models reveal that oncolytic virus therapy success depends on viral spread dynamics. Fast-spreading viruses can eliminate tumors, while slow-spreading ones may fail even with high replication rates.

Area of Science:

  • Oncology
  • Virology
  • Mathematical Biology

Background:

  • Replicating oncolytic viruses offer a promising cancer therapy by selectively targeting and destroying cancer cells.
  • Despite promising clinical trial results, consistent success in oncolytic virus therapy remains a challenge.
  • Mathematical models are crucial for understanding the dynamics of oncolytic virus therapy but are often limited by model-specific assumptions.

Purpose of the Study:

  • To develop a general, expression-independent computational framework for ordinary differential equation (ODE) modeling of oncolytic virus therapy.
  • To investigate the conditions for successful oncolytic virus therapy by analyzing the developed framework.
  • To gain new insights into the dynamics of virus-tumor interactions.

Main Methods:

  • Formulated a general computational framework for ODE modeling of oncolytic virus therapy, independent of specific mathematical expressions.
  • Analyzed the framework to identify distinct dynamic behaviors based on virus spread assumptions.
  • Simulated treatment outcomes under different spread scenarios (fast vs. slow).

Main Results:

  • Identified two distinct types of dynamics in oncolytic virus therapy models: 'fast spread' and 'slow spread'.
  • In 'fast spread' models, high viral replication rates can lead to tumor elimination.
  • In 'slow spread' models, treatment failure can occur even with high viral replication rates due to suboptimal virus dissemination.

Conclusions:

  • The dynamics and success of oncolytic virus therapy are highly dependent on the assumed virus spread mechanisms within the tumor.
  • 'Fast spread' is crucial for effective tumor elimination, whereas 'slow spread' poses a significant challenge to treatment efficacy.
  • The developed modeling framework offers a versatile tool for studying various biological systems beyond oncolytic virus therapy.

More Related Videos

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...